Skip to main content
SpringerLink
Log in

Dissociated thyromimetic effects of 3, 5, 3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels1

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Although TRIAC is bound at least twice as avidly to nuclear receptor as T3, its thyromimetic potency is relatively low and its effect at the pituitary level on thyrotropin (TSH) secretion seems to be dissociated from that at the peripheral tissue level. In order to gain further insight into the complex effects of this thyroid hormone analog, we studied the effects of long-term TRIAC administration (2.8 mg/day for 2 months) on TSH secretion, circulating free thyroid hormone (FT4 and FT3) levels and some parameters able to evaluate the peripheral thyroid hormone action, in 5 mild obese subjects on low caloric diet (1200 kcal /day). The results were compared to those obtained in 5 mild obese subjects matched for age, sex and weight on low caloric diet alone. TRIAC administration completely inhibited the secretion of both basal and TRH-stimulated TSH in few days, and consequently serum FT4 and FT3 concentrations progressively dropped to very low levels, while no significant changes in both TSH and free thyroid hormone levels were recorded in the control group. The body weight significahtly fell in both groups, without any difference between TRIAC treated and untreated patients. The heart rate was constant throughout the course of the study in both groups of patients. Serum total cholesterol, triglyceride and total lipid concentrations significantly decreased in both groups, and the decrement recorded in TRIAC treated patients was not significantly different from that found in patients on diet alone. The low serum levels of sex hormone-binding globulin (SHBG) completely normalized in both groups (TRIAC + diet: from 19.9 ± 7.4 to 49.0 ± 14.5 nmol /l, p < 0.01; diet alone: from 29.0 ± 6.0 to 50.6 ± 5.2 nmol/l, p < 0.01), without any difference between TRIAC treated and untreated patients. The present data confirm the previously reported discrepancy between the strong in vitro nuclear binding of TRIAC and its poor thyromimetic activity in vivo, and demonstrate that TRIAC at the dose which completely suppresses TSH secretion does not cause any particular metabolic effect at the peripheral tissue level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Koerner D., Schwartz H.L., Surks M.I., Oppenheimer J.H., Jorgensen.C. Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei: high correlation between structural requirements for nuclear binding and biological activity. J. Biol. Chem. 250: 6417, 1975.

    PubMed  CAS  Google Scholar 

  2. De Groot L.J., Reed Larsen P., Refetoff S., Stanbury J.B. The thyroid and its diseases, ed. 5. Wiley Medical, New York, 1986, p. 87.

    Google Scholar 

  3. Goslings B., Schwartz H.L., Dillmann W., Surks M.I., Oppenheimer J.H. Comparison of the metabolism and distribution of LT3 and TRIAC in the rat: a possible explanation of differential hormone potency. Endocrinology 98: 666, 1976.

    Article  PubMed  CAS  Google Scholar 

  4. Christensen L.K. The binding to serum protein of acetic and propionic acid analogues of thyroxine and triiodothyronine. Endocrinology 67: 407, 1960.

    Article  PubMed  CAS  Google Scholar 

  5. De Groot L.J., Refetoff S., Bernal J., Rue P.A., Coleoni A.H. Nuclear receptors for thyroid hormones. J. Endocrinol. Invest. 1: 79, 1978.

    Article  Google Scholar 

  6. Lerman J. Dissociation of response to triiodothyroacetic acid in myxedema: comparison with response to thyroid substance. J. Clin. Endocrinol. Metab. 21: 1044, 1961.

    Article  PubMed  CAS  Google Scholar 

  7. Medeiros-Neto G., Kallas W.G., Knobel M., Cavaliere H., Mattar E. TRIAC (3, 5, 3′-triiodothyroacetic acid) partially inhibits the thyrotropin response to synthetic thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients. J. Clin. Endocrinol. Metab. 50: 223, 1980.

    Article  PubMed  CAS  Google Scholar 

  8. Trotter W.R. Effect of triiodothyroacetic acid on blood cholesterol levels. Lancet 1: 885, 1956.

    Article  Google Scholar 

  9. Beck-Peccoz P., Piscitelli G., Cattaneo M.G., Faglia G. Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH hypersecretion with 3, 5, 3′-triiodothyroacetic acid (TRIAC). J. Endocrinol. Invest. 6: 217, 1983.

    Article  PubMed  CAS  Google Scholar 

  10. Faglia G., Beck-Peccoz P., Piscitelli G., Medri G. Inappropriate secretion of TSH by the pituitary. Horm. Res. 26: 79, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Anderson D.C. Sex hormone binding globulin. Clin. Endocrinol. (Oxf.) 3: 69, 1974.

    Article  CAS  Google Scholar 

  12. Yosha S., Fay M., Longcope C., Braverman L.E. Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects. J. Endocrinol. Invest. 7: 489, 1984.

    Article  PubMed  CAS  Google Scholar 

  13. Garrow J.S., Webster J. Quetelet’s (W/H2) as a measure of fatness. Int. J. Obesity 9: 147, 1985.

    CAS  Google Scholar 

  14. Romelli P.B., Pennisi F., Vancheri L. Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay. J. Endocrinol. Invest. 2: 25, 1979.

    Article  PubMed  CAS  Google Scholar 

  15. Keppel G. Design and analysis. A researcher’s handbook. Prentice-Hall Inc, Engelwood Cliffs, New Jersey, 1973.

    Google Scholar 

  16. Spiegel G. Mathematical handbook. Mc Graw-Hill, New York, 1968.

    Google Scholar 

  17. Glass A.R., Swerdloff R.S., Bray G.A., Dahms W.T., Atkinson R.L. Low serum testosterone and sex hormone-binding globulin in massively obese men. J. Clin. Endocrinol. Metab. 45: 1211, 1977.

    Article  PubMed  CAS  Google Scholar 

  18. Burger A.G., Engler D., Sakoloff C., Staeheli V. The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects. Acta Endocrinol. (Kbh.) 92: 453, 1979.

    Google Scholar 

  19. Sterling K. Thyroid hormone action at cell level. N. Engl. J. Med. 300: 117, 1979.

    Article  PubMed  CAS  Google Scholar 

  20. Jorgensen E.C., Bolger M.B., Dietrich S.W. Thyroid hormone analogs: correlation between structure, nuclear binding and hormonal activity. In: James V.H.T. (Ed.), Endocrinology. Excerpta Medica, International Congress Series 403, Amsterdam, 1977, p. 117.

    Google Scholar 

  21. Vagenakis A.G., Rapoport B., Azizi F., Portnay G.I., Braverman L.E., Ingbar S.H. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J. Clin. Invest. 54: 913, 1974.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. Saberi M., Utiger R.D. Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations. J. Clin. Endocrinol. Metab. 40: 435, 1975.

    Article  PubMed  CAS  Google Scholar 

  23. Oppenheimer J.H., Schwartz H.L. Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain and heart. J. Clin. Invest. 75: 147, 1985.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Orgiazzi J., Ducottet X., Barbier Y., Jordan D., Pugeat M., Morin M.H. Inappropriate TSH hypersecretion: opposite effect of T4 and T3 on the thyrotrophs? Ann. Endocrinol. (Paris) 45: 89A, 1984.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Endocrinologia e Medicina Costituzionale, University of Milano, Italy

    P. Beck-Peccoz M.D., A. Sartorio & G. Faglia

  2. Centro Auxologico Italiano, Milano, Italy

    C. De Medici & G. Grugni

  3. Department of Endocrinology, Ospedale Maggiore IRCCS, Pad. Sacco, Via F. Sforza 35, I-20122, Milano, Italy

    F. Morabito

Authors
  1. P. Beck-Peccoz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Sartorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. De Medici
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Grugni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Morabito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Faglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by grants from Ospedale Maggiore IRCCS, and Centro Auxologico Italiano IRCCS, Milano, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beck-Peccoz, P., Sartorio, A., De Medici, C. et al. Dissociated thyromimetic effects of 3, 5, 3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels1. J Endocrinol Invest 11, 113–118 (1988). https://doi.org/10.1007/BF03350116

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350116

Key-words

Search

Navigation